This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Banks' Excess Capital Is 'Absolutely a Reality'

NEW YORK (TheStreet) -- There are two big days coming up this month for bank stock investors, which will underline large U.S. banks' continued increase in excess capital, according to Oppenheimer analyst Chris Kotowski.

The Federal Reserve on March 20 will announce the results of its annual stress tests on 30 major bank holding companies, which is an increase from the group of 18 that has been tested over the previous several years. The tests are based on Sept. 30 financial statements, and are meant to gauge the banks' ability to remain well capitalized through a "severely adverse" economic scenario.

This year's scenario assumes an increase in the U.S. unemployment of four percentage points, with the unemployment rate peaking at 11.25% in mid-2015. The scenario also includes a decline in real U.S. GDP of nearly 4.75% through the end of 2014, a 50% decline in equity prices and a 25% decline in home prices.

The only bank to fail last year's stress tests was Ally Financial, the former GMAC, which still has the majority of its common shares held by the federal government.

Must Read: Stop Buying U.S. Bancorp Stock, Says KBW

Following the completion of the stress tests, the Federal Reserve will run a second set of tests to incorporate the banks' plans to deploy excess capital through dividend increases, share buybacks and acquisitions. This part of the process is called the Comprehensive Capital Analysis and Review (CCAR).

Only two banks had their capital plans rejected outright by the Fed last year -- Ally Financial and BB&T (BBT) of Winston-Salem, N.C.. The regulator cited "a qualitative assessment" in its "objection" to BB&T's capital plan. A revised plan from BB&T was accepted by the Fed in August, but included no dividend increase or share buybacks through the first quarter of 2014.

JPMorgan Chase (JPM - Get Report) and Goldman Sachs (GS) both received "conditional approval" for their 2013 capital plans, and both companies had revised plans accepted by the Federal Reserve in August.

Kotowski, in a note to clients on Monday, wrote that for the 11 large-cap banks covered by his firm, the aggregate Basel III Tier 1 common equity ratio rose to 10% at the end of 2013 from 9% a year earlier, even after the banks had made dividend payments and stock repurchases totaling "52% of actual 2013 earnings."

For 2014, Kotowski expects the banks to return about 65% of "run-rate" earnings to investors through dividends and buybacks, while seeing their aggregate Basel III Tier 1 common equity ratio climb to 10.5%.

"The point we would take away is that in years past excess capital was hypothetical; this year it is absolutely a reality and with each passing CCAR, we think investors will regain more confidence and improve multiples," the analyst said.

Multiples are a sore point for investors holding shares of many large-cap bank stocks.

JPMorgan, for example, trades for 9.3 times the consensus 2015 EPS estimate of $6.35, among analysts polled by Thomson Reuters, based on Monday's closing price of $59.20. That compares to an average forward price-to-earnings ratio of 12.7 for the 24 component stocks of the KBW Bank Index.

JPMorgan's return on average tangible common equity (ROTCE) for 2013 was a relatively low 11.92%, according to Thomson Reuters Bank Insight, reflecting the third-quarter loss the company booked as it prepared for $17.5 billion in residential mortgage-backed securities settlements in the fourth quarter. JPM's 2012 ROTCE was 14.72%, and the company's outlook calls for ROTCE to improve to a range of 15% to 16% over the next four years.

It's a pretty safe bet that JPMorgan's performance will improve this year, with lower litigation expenses.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
C $51.79 0.08%
JPM $62.68 0.18%
AAPL $110.37 -1.75%
FB $88.15 -1.94%
GOOG $606.25 -1.32%

Markets

Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs